Progenics Pharmaceuticals, Inc. Contracts & Agreements
64 Contracts & Agreements
- Business Finance (16 contracts)
- Business Operations (4)
- Human Resources (21)
- Intellectual Property (9)
- Mergers & Acquisitions (3)
- Real Estate (3)
- Uncategorized (8)
- Bridge Loan Agreement, dated as of March 15, 2020, between Progenics Pharmaceuticals, Inc. and Lantheus Medical Imaging, Inc (Filed With SEC on March 16, 2020)
- Description of Capital Stock (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Asha Das (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Benedict Osorio (Filed With SEC on March 13, 2020)
- Employment Offer Letter Agreement between the Registrant and Bryce Tenbarge (Filed With SEC on March 13, 2020)
- Consulting Services Agreement, dated November 15, 2019, between the Registrant and David Mims (Filed With SEC on March 13, 2020)
- Form of Retention Bonus Agreement (Filed With SEC on March 13, 2020)
- Consulting Services Agreement, dated as of March 4, 2020, by and between Progenics Pharmaceuticals, Inc. and Patrick Fabbio (Filed With SEC on March 4, 2020)
- Amended and Restated Agreement and Plan of Merger, dated as of February 20, 2020, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc (Filed With SEC on February 20, 2020)
- Form of Non-Qualified Stock Option Award Agreement for Directors under the 2018 Performance Incentive Plan (Filed With SEC on November 7, 2019)
- Form of Non-Qualified Stock Option Award Agreement for Employees under the 2018 Performance Incentive Plan (Filed With SEC on November 7, 2019)
- Agreement and Plan of Merger, dated as of October 1, 2019, among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc (Filed With SEC on October 2, 2019)
- Amendment to the Stock Purchase and Sale Agreement, dated May 9, 2019, by and between Progenics Pharmaceuticals, Inc., Molecular Insight Pharmaceuticals, Inc., and Highland... (Filed With SEC on May 14, 2019)
- Underwriting Agreement, dated as of August 7, 2018, by and among Progenics Pharmaceuticals, Inc. and Jefferies LLC and Credit Suisse Securities (USA) LLC, as representatives of... (Filed With SEC on August 10, 2018)
- Progenics Pharmaceuticals, Inc. 2018 Performance Incentive Plan (Filed With SEC on June 14, 2018)
- Settlement and License Agreement by and among Progenics Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Wyeth LLC, and Actavis... (Filed With SEC on May 31, 2018)
- Settlement and License Agreement by and among Progenics Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Wyeth LLC, and Par Sterile... (Filed With SEC on May 11, 2018)
- Loan agreement, dated as of November 4, 2016, by and between Healthcare Royalty Partners III, L.P., as Lender, and MNTX Royalties Sub LLC, as Borrower (Filed With SEC on November 7, 2016)
- Assignment and Assumption Agreement, dated May 6, 2016, between Progenics Pharmaceuticals, Inc., BMR-Landmark at Eastview LLC and Regeneron Pharmaceuticals, Inc (Filed With SEC on May 10, 2016)
- License Agreement, dated April 28, 2016, between PSMA Development Company LLC and Bayer AS (Filed With SEC on May 4, 2016)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 11, 2016)
- Employment Information for New Employees (Filed With SEC on March 11, 2016)
- Employment Information for New Employees (Filed With SEC on March 11, 2016)
- Lease, dated December 31, 2015, between Progenics Pharmaceuticals, Inc. and WTC TOWER 1 LLC (Filed With SEC on January 5, 2016)
- Agreement, dated September 19, 2014, between the Registrant and Dr. Hagop Youssoufian (Filed With SEC on November 7, 2014)
- 2005 Stock Incentive Plan, as amended effective June 17, 2014 (Filed With SEC on June 18, 2014)
- LICENSE AGREEMENT This agreement ("Agreement") is made by and between University of Zurich Ramistrasse 71 CH-8006Zurich(Switzerland) (,UniversityofZurich") and... (Filed With SEC on March 13, 2014)
- 7,608,696 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on February 21, 2014)
- 8,500,000 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 21, 2013)
- 2005 Stock Incentive Plan, as amended, of the Registrant (Filed With SEC on June 17, 2013)
- STOCK PURCHASE AND SALE AGREEMENT BY AND BETWEEN THE STOCKHOLDERS OF MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE "STOCKHOLDERS") MOLECULAR INSIGHT PHARMACEUTICALS, INC. (THE... (Filed With SEC on May 10, 2013)
- LICENSE GREEMENT (Filed With SEC on May 10, 2013)
- 11,000,000 Shares Progenics Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on November 30, 2012)
- AMENDED AND RESTATED AGREEMENT OF LEASE between BMR-LANDMARK AT EASTVIEW LLC, Landlord and PROGENICS PHARMACEUTICALS, INC., Tenant Dated: October 28, 2009 The Landmark at Eastview... (Filed With SEC on November 28, 2012)
- PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (As amended and effective as of June 13, 2012) (Filed With SEC on November 28, 2012)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2011)
- 2010 AGREEMENT RELATED TO PROGENICSs MNTX IN-LICENSE (Filed With SEC on May 10, 2011)
- FIRST AMENDMENT TO TERMINATION AND TRANSITION AGREEMENT (Filed With SEC on March 15, 2011)
- TERMINATIONAND TRANSITION AGREEMENT BY ANDAMONG WYETH, ACTINGTHROUGH ITS WYETHPHARMACEUTICALS DIVISION, and WYETH-WHITEHALLPHARMACEUTICALS, INC., and WYETH-AYERSTLEDERLE, INC.,... (Filed With SEC on March 15, 2010)
- LICENSEAGREEMENT by andamong ONOPHARMACEUTICAL CO., LTD. and PROGENICSPHARMACEUTICALS, INC. Dated asof October 16, 2008 (Filed With SEC on March 13, 2009)
- CONSENT, ACKNOWLEDGMENT ANDAGREEMENT (Filed With SEC on March 13, 2009)
- PARTIALTERMINATION AND LICENSE AGREEMENT (Filed With SEC on March 13, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 17, 2008)
- 2,600,000 Shares (Filed With SEC on September 24, 2007)
- Exhibit 10.6 PROGENICS PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 9, 2007)
- MEMBERSHIP INTEREST PURCHASE AGREEMENT by and between PROGENICS PHARMACEUTICALS, INC. and CYTOGEN CORPORATION Dated April 20, 2006 TABLE OF CONTENTS (Filed With SEC on August 8, 2006)
- AMENDED AND RESTATED PSMA/PSMP LICENSE AGREEMENT by and among PROGENICS PHARMACEUTICALS, INC., CYTOGEN CORPORATION and PSMA DEVELOPMENT COMPANY LLC Dated April 20, 2006 (Filed With SEC on August 8, 2006)
- LICENSE AND CO-DEVELOPMENT AGREEMENT by and among WYETH, acting through its WYETH PHARMACEUTICALS DIVISION, WYETH-WHITEHALL PHARMACEUTICALS, INC., WYETH-AYERST LEDERLE, INC., and... (Filed With SEC on March 15, 2006)
- EXHIBIT 10.27 OPTION AND LICENSE AGREEMENT (Filed With SEC on March 15, 2006)
- AGREEMENT AND PLAN OF REORGANIZATION by and among PROGENICS PHARMACEUTICALS, INC., PROGENICS PHARMACEUTICALS NEVADA, INC. UR LABS, INC. and SHAREHOLDERS OF UR LABS, INC. Dated as... (Filed With SEC on December 28, 2005)
- Progenics Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on September 15, 2005)
- Progenics Pharmaceuticals, Inc. 1,532,467 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on June 13, 2005)
- PROGENICS PHARMACEUTICALS, INC. 2005 STOCK INCENTIVE PLAN (Filed With SEC on May 13, 2005)
- PROGENICS SUPPLY AGREEMENT (Filed With SEC on May 10, 2005)
- Progenics Pharmaceuticals, Inc. 2,000,000 Shares Common Stock ($0.0013 par value) Underwriting Agreement (Filed With SEC on April 5, 2005)
- Summary of Non-employee Director Compensation (Filed With SEC on March 16, 2005)
- Description of Compensation Arrangement with respect to Named Executive Officers (Filed With SEC on March 16, 2005)
- PROGENICS PHARMACEUTICALS, INC. Non-Qualified Stock Option Agreement Option Certificate Number: (Filed With SEC on January 14, 2005)
- PROGENICS PHARMACEUTICALS, INC. RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on January 14, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2004)
- AWARD/CONTRACT (Filed With SEC on November 14, 2003)
- AGREEMENT OF LEASE between EASTVIEW HOLDINGS LLC, Landlord and PROGENICS PHARMACEUTICALS, INC., Tenant Dated: September 30, 2003 The Landmark at Eastview Towns of Greenburgh and... (Filed With SEC on November 14, 2003)
- EASTVIEW HOLDINGS LLC 777 Old Saw Mill River Road Tarrytown, New York 10591 October 23, 2003 (Filed With SEC on November 14, 2003)
- Exclusive Sublicense Agreement, dated September 21, 2001, between the Registrant and UR Labs, Inc (Filed With SEC on March 31, 2003)